Article Text
Statistics from Altmetric.com
Acute ischemic stroke (AIS) is an emergency that requires rapid treatment by skilled practitioners in order to avoid severe disability or death. It is estimated that AIS accounts for up to 87% of all stroke-related cases worldwide. In the USA the incidence of AIS is approximately 750 000 patients annually, and this rate is expected to increase 25% in the next 20 years.1
The last decade has witnessed remarkable progress in the treatment of this condition. In 2015, five multicenter prospective randomized clinical trials (RCTs) demonstrated that thrombectomy is overwhelmingly superior to medical management for patients with emergent large vessel occlusion.2–6 Shortly thereafter, in 2016, the Society of Vascular and Interventional Neurology (SVIN) guideline writing committee published recommendations for appropriate hospital and individual requirements in order to demonstrate adequate expertise in thrombectomy.7 These recommendations were in part based on the Stroke Chain of Survival endorsed in the American Heart Association/American Stroke Association 2013 guidelines for the early management of patients with acute ischemic stroke.8 …
Footnotes
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
Patient consent for publication Not required.